Studies have shown that impaired pDC functions correlate with poor prognosis in HCC patients [22], underscoring the importance of strategies to restore or enhance pDC’s anti-tumor activity in HCC as a potential therapeutic approach. Here, PDC is linked to hepatocellular carcinoma.